Daiichi Sankyo reported JPY340.48B in Sales Revenues for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Astellas Pharma 4503:JP JPY 380.39B 1.4B
Chugai Pharma 4519:JP JPY 225.28B 10.33B
Daiichi Sankyo 4568:JP JPY 340.48B 13B
Eisai 4523:JP JPY 174.36B 9.9B
Kyowa Hakko Kirin 4151:JP JPY 98.5B 984M
M3 2413:JP JPY 55.62B 1.38B
Otsuka Holdings 4578:JP JPY 451.81B 17.81B
Shionogi 4507:JP JPY 187.57B 108.63B
Sumitomo Dainippon 4506:JP JPY 140.98B 18.44B
Takeda 4502:JP JPY 1T 29.84B
Terumo 4543:JP JPY 205.98B 8.64B